SG10201404221RA - Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof - Google Patents

Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof

Info

Publication number
SG10201404221RA
SG10201404221RA SG10201404221RA SG10201404221RA SG10201404221RA SG 10201404221R A SG10201404221R A SG 10201404221RA SG 10201404221R A SG10201404221R A SG 10201404221RA SG 10201404221R A SG10201404221R A SG 10201404221RA SG 10201404221R A SG10201404221R A SG 10201404221RA
Authority
SG
Singapore
Prior art keywords
activating
preparation
therapeutic use
fgf receptor
octasaccharides
Prior art date
Application number
SG10201404221RA
Inventor
Philippe Duchaussoy
Pierre Fons
Corentin Herbert
Gilbert Lassalle
Pierre Alexandre Driguez
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42035764&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201404221R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG10201404221RA publication Critical patent/SG10201404221RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
SG10201404221RA 2009-08-14 2010-08-12 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof SG10201404221RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903968A FR2949114B1 (en) 2009-08-14 2009-08-14 FGF RECEPTOR ACTIVATORY N-ACYLATED OCTASACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
SG10201404221RA true SG10201404221RA (en) 2014-09-26

Family

ID=42035764

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2012010203A SG178405A1 (en) 2009-08-14 2010-08-12 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof
SG10201404221RA SG10201404221RA (en) 2009-08-14 2010-08-12 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2012010203A SG178405A1 (en) 2009-08-14 2010-08-12 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof

Country Status (27)

Country Link
US (1) US9012413B2 (en)
EP (1) EP2464667A2 (en)
JP (1) JP5671536B2 (en)
KR (1) KR101718567B1 (en)
CN (1) CN102574931B (en)
AR (1) AR078094A1 (en)
AU (1) AU2010283614B2 (en)
BR (1) BR112012007883A2 (en)
CA (1) CA2771056C (en)
CL (1) CL2012000393A1 (en)
CO (1) CO6612193A2 (en)
DO (1) DOP2012000037A (en)
EA (1) EA020485B1 (en)
EC (1) ECSP12011671A (en)
FR (1) FR2949114B1 (en)
IL (1) IL218068A (en)
MA (1) MA33573B1 (en)
MX (1) MX2012001947A (en)
NI (1) NI201200026A (en)
NZ (1) NZ598174A (en)
PE (1) PE20120915A1 (en)
SG (2) SG178405A1 (en)
TN (1) TN2012000052A1 (en)
TW (1) TWI572615B (en)
UY (1) UY32843A (en)
WO (1) WO2011018588A2 (en)
ZA (1) ZA201201028B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949114B1 (en) 2009-08-14 2011-08-26 Sanofi Aventis FGF RECEPTOR ACTIVATORY N-ACYLATED OCTASACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2949115B1 (en) * 2009-08-14 2012-11-02 Sanofi Aventis FGF RECEPTOR ACTIVATOR N-SULFATE OLIGOSACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2970969B1 (en) * 2011-01-27 2013-10-18 Sanofi Aventis OLIGOSACCHARIDES 3-O-ALKYL ACTIVATORS OF FGFS RECEPTORS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
US9315587B2 (en) * 2011-03-10 2016-04-19 Victoria Link Limited Oligosaccharide compounds
CN104370980B (en) * 2014-10-17 2017-12-01 九芝堂股份有限公司 A kind of oligosaccharide compound and its pharmaceutical composition for suppressing endogenous factors X enzymatic activitys

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US481816A (en) * 1892-08-30 Coin-controlled mechanism
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
EP0333243A3 (en) * 1988-03-10 1989-09-27 Akzo N.V. Sulphated k5 antigen and sulphated k5 antigen fragments
WO1992018546A1 (en) * 1991-04-17 1992-10-29 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (en) 1993-04-22 1995-07-21 Sanofi Elf 3-DESOXY OLIGOSACCHARIDES, THEIR PREPARATION PROCESSES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
EP0649854B1 (en) 1993-09-01 2000-03-15 Akzo Nobel N.V. Bisconjugates comprising two saccharides and a spacer
FR2749849B1 (en) * 1996-06-14 1998-09-04 Sanofi Sa SYNTHETIC POLYSACCHARIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2751334B1 (en) 1996-07-19 1998-10-16 Sanofi Sa SYNTHETIC POLYSACCHARIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2773804B1 (en) 1998-01-19 2000-02-18 Sanofi Sa SYNTHESIS POLYSACCHARIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US6617316B1 (en) 1999-10-22 2003-09-09 Aventis Pharma Oligosaccharides, their preparation and pharmaceutical compositions containing them
FR2800074B1 (en) * 1999-10-22 2001-12-21 Aventis Pharma Sa NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7582737B2 (en) 2004-07-20 2009-09-01 Academia Sinica Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides
FR2873377B1 (en) * 2004-07-23 2006-10-13 Sanofi Synthelabo AZASUCRE DERIVATIVES, HEPARANASES INHIBITORS, PROCESS FOR THE PREPARATION THEREOF, COMPOSITIONS CONTAINING SAME AND USE THEREOF
EP2019843A2 (en) * 2006-05-25 2009-02-04 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
FR2949114B1 (en) 2009-08-14 2011-08-26 Sanofi Aventis FGF RECEPTOR ACTIVATORY N-ACYLATED OCTASACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
TW201109020A (en) 2011-03-16
SG178405A1 (en) 2012-03-29
ZA201201028B (en) 2013-07-31
KR20120106716A (en) 2012-09-26
AU2010283614A1 (en) 2012-03-08
FR2949114B1 (en) 2011-08-26
DOP2012000037A (en) 2012-04-15
IL218068A (en) 2015-07-30
CN102574931A (en) 2012-07-11
PE20120915A1 (en) 2012-08-17
UY32843A (en) 2011-03-31
TN2012000052A1 (en) 2013-09-19
CN102574931B (en) 2014-07-02
MX2012001947A (en) 2012-09-12
CA2771056A1 (en) 2011-02-17
US20120214754A1 (en) 2012-08-23
JP5671536B2 (en) 2015-02-18
KR101718567B1 (en) 2017-03-21
CL2012000393A1 (en) 2012-09-07
NI201200026A (en) 2012-05-24
WO2011018588A2 (en) 2011-02-17
FR2949114A1 (en) 2011-02-18
US9012413B2 (en) 2015-04-21
TWI572615B (en) 2017-03-01
ECSP12011671A (en) 2012-03-30
IL218068A0 (en) 2012-04-30
EP2464667A2 (en) 2012-06-20
EA201270277A1 (en) 2012-09-28
BR112012007883A2 (en) 2016-03-15
MA33573B1 (en) 2012-09-01
WO2011018588A3 (en) 2011-07-07
EA020485B1 (en) 2014-11-28
CA2771056C (en) 2017-11-14
CO6612193A2 (en) 2013-02-01
JP2013501839A (en) 2013-01-17
NZ598174A (en) 2014-01-31
AR078094A1 (en) 2011-10-12
AU2010283614B2 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
ZA201005201B (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
IL207078A0 (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
IL231386A0 (en) Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
HK1176002A1 (en) Modifying pirfenidone treatment for patients with fibrosis
IL236360A0 (en) Inhalable medicament
GB0817207D0 (en) therapeutic apsac compounds and their use
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
HK1167597A1 (en) Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics -2e4e-
SI2146991T1 (en) Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
ZA201200027B (en) Pyrazole derivatives, preparaton thereof, and therapeutic use thereof
ZA201201028B (en) Fgf receptor-activating n-acyl octasaccharides,preparation thereof,and therapeutic use thereof
GB0905970D0 (en) Depsipeptides and their therapeutic use
IL218069A0 (en) Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
HK1164861A1 (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
PL2477990T3 (en) 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof
IL202474A0 (en) 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
SI2421864T1 (en) 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof
IL226388A0 (en) Novel indolizine derivatives, and preparation and therapeutic use thereof
IL220859A0 (en) Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application
GB0913955D0 (en) Lactams and their therapeutic use
GB0817740D0 (en) New therapeutic use
GB0817737D0 (en) New therapeutic use